Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew J. Klaben currently holds 327,286 shares of Sotera Health Co (SHC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew J. Klaben has been a net seller of SHC stock. They have purchased $60.7K and sold $5.8M worth of shares.
Matthew J. Klaben's most recent insider trade was on Mar 22, 2021, when they sold 41,952 shares at $26.12 per share.
Matthew J. Klaben serves as Executive at Sotera Health Co (SHC). They have executed 45 insider transactions totaling $5.8M over their tenure at the company.
Matthew J. Klaben holds the position of Executive at Sotera Health Co, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Matthew J. Klaben has shown a selling trading pattern, with $60.7K in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew J. Klaben was on Nov 1, 2011, when they sold $1.6M worth of GTLS shares. This transaction involved 30,000 shares at $54.14 per share.
Matthew J. Klaben currently owns 327,286 shares of Sotera Health Co (SHC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew J. Klaben's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew J. Klaben has 45 Form 4 filings on record as an insider at Sotera Health Co.
Set alerts for Matthew J. Klaben and 40,000+ other insiders.